Miller et al. showed that metastatic formation was inhibited when treating mice with pancreatic cancer with a LOX-blocking antibody, while no survival effect was shown with the antibody alone, indicating that the primary tumour was unaffected by the treatment8. The gene discussed is LOX; the disease is familial pancreatic carcinoma.